Username Password
S&P 500: 1,992.37
Change: +0.29%

EXELIXIS INC. (EXEL)

Overview
Price 4.09
Price Change Today -$0.02 (-0.49%)
P&P rating Rating: 3
Open Price $4.10
Previous Close $4.11
Daily Range $4.05 - $4.18
52-Week Range $3.02 - $8.41
Volume 1
chart
Top Buy Analysis
BUY: EXEL Rating: 3
Company: EXELIXIS INC.
Points: -75.76
Start Price: $5.57
Start Date: 06/11/2008 6:52 PM
GreedsGood
GreedsGood
P&P Score: 61.93
Recs:
Undervalued

Comments: 0 | Comment

Top Sell Analysis
SELL: EXEL Rating: 3
Company: EXELIXIS INC.
Points: 112.95
Start Price: $9.35
Start Date: 06/19/2011 9:24 AM
Hqdepot
Hqdepot
P&P Score: 49.53
Recs:
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

28 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/10/10 Zantrio.com Free Daily Stock Picks 3-10-2010 0
zantriocom
0.00 11/09/09 Zantrio.com Free Daily Stock Picks 11-9-09 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 12/20/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Sanofi Launches Cancer Treatment - Analyst Blog 0
Zacks_Analysts
0.00 06/30/10 Sanofi to Acquire TargaGen - Analyst Blog 0
Zacks_Analysts
0.00 06/22/10 BMY Terminates EXEL Partnership - Analyst Blog 0
Zacks_Analysts
0.00 06/18/10 FDA Approves Sanofi Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/07/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -34.97
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +112.95
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $12.35
Points: -114.77
Created: 04/26/2011
Ready to break out of weekly and monthly charts plus close to breaking out of short term consolidation

Comments: 1 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.21
Points: -103.74
Created: 12/14/2010
promising medicin

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -75.76
Created: 06/11/2008
Undervalued

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $6.50
Points: -81.75
Created: 06/04/2008
Phase 2 and 3's are coming!!!! 500% gain in 5 years if not more.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -91.25
Created: 10/19/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.33
Points: -75.86
Created: 10/12/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $3.58
Points: -79.55
Created: 07/06/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.20
Points: -78.92
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
BriansLongshots 1.72 BUY Three Plus Years 05/23/2013 $4.77 $4.09
(-0.49%)
-14.26% +20.71% -34.97 view
rtezanos 99.30 BUY Week or Less 10/19/2011 $5.57 $4.09
(-0.49%)
-26.57% +64.68% -91.25 view
Hqdepot 49.53 SELL Six Months to a Year 06/19/2011 $9.35 $4.09
(-0.49%)
-56.26% +56.69% +112.95 view
wallstreeter 0.38 BUY Six Months to a Year 04/26/2011 $12.35 $4.09
(-0.49%)
-66.88% +47.89% -114.77 view
cmmtgnmn 60.76 BUY Six Months to a Year 12/14/2010 $7.21 $4.09
(-0.49%)
-43.27% +60.47% -103.74 view
EyePhone 62.24 BUY One to Three Months 10/12/2010 $4.33 $4.09
(-0.49%)
-5.54% +70.32% -75.86
HardTimes 61.24 BUY One to Three Months 07/06/2010 $3.58 $4.09
(-0.49%)
+14.25% +93.80% -79.55
GreedsGood 61.93 BUY One to Three Years 06/11/2008 $5.57 $4.09
(-0.49%)
-26.57% +49.19% -75.76 view
POTASHKing 10.59 BUY Three Plus Years 06/04/2008 $6.50 $4.09
(-0.49%)
-37.08% +44.67% -81.75 view
Dave Brushart 68.14 BUY Six Months to a Year 01/01/2008 $7.20 $4.09
(-0.49%)
-43.19% +35.72% -78.92
Pages: [ 1 ]  2   3  >>
Sponsored Links